Skip to news
JQJO
Latest

Novo Nordisk cuts Wegovy and Ozempic prices | JQJO

Novo Nordisk cuts Wegovy and Ozempic prices

Novo Nordisk cuts Wegovy and Ozempic prices

Tap title to read story

0:00 / 0:50

Novo Nordisk cut direct-to-consumer prices for Wegovy and Ozempic to $349 a month for cash-paying patients, while the highest Ozempic dose stays $499. A temporary offer lets new cash payers get the two lowest doses for $199 a month for the first two months, ending March 31. The moves follow deals with the Trump administration, including lower prices paid by the government, Medicare coverage of obesity drugs for certain patients, and discounted medicines on the TrumpRx site launching in January. The administration set starting doses at $350, trending to $245; Eli Lilly also trimmed Zepbound prices on LillyDirect.

Published · Published by JQJO

Published by JQJO Editorial Desk · AI assisted

More context

Sources

JQJO Editorial Desk · Human reviewed · AI assisted. Report a correction.

Editorial policy and corrections · Our team

Splatoon 3 Version 12.0.0

Tap title to read story

0:00 / 0:00

JQJO

Find your next story

Search JQJO’s current coverage.